PTC Therapeutics, Inc. (PTCT) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -59.04M | -34.27M | -66.3M | -58.33M | 870.1M | -30M | -76.99M | -71.45M | 70.76M | -100.29M | -14.52M | -14.12M |
| Operating CF Margin % | -21.66% | -20.81% | -31.42% | -32.61% | 73.98% | -14.07% | -39.12% | -38.27% | 33.68% | -32.66% | -7.39% | -6.6% |
| Operating CF Growth % | -106.79% | -14.23% | 13.89% | 18.36% | 1129.64% | 70.08% | -430.28% | -406.04% | 339.94% | 39.57% | 61.84% | 74.44% |
| Net Income | -2.81M | -134.97M | 15.9M | -64.85M | 866.56M | -65.89M | -106.65M | -99.18M | -91.58M | -155.79M | -132.97M | -198.88M |
| Depreciation & Amortization | 0 | 12.9M | 11.11M | 7.58M | 7.22M | 6.76M | 6.49M | 7.02M | 55.4M | 80.7M | 62.05M | 51.01M |
| Stock-Based Compensation | 0 | 0 | 19.43M | 18.54M | 18.06M | 17.24M | 19.75M | 19.24M | 18.38M | 16.51M | 26.94M | 58.94M |
| Deferred Taxes | 0 | 1K | -4K | -2K | 2K | -55.91M | -3K | 2K | -1K | 3.98M | -2K | -50.9M |
| Other Non-Cash Items | 54.47M | -3.32M | -27.85M | -2.89M | 15.65M | 31.21M | -8.21M | 12.64M | 23.05M | 36.92M | 21.95M | 93.33M |
| Working Capital Changes | -110.7M | 91.11M | -84.88M | -16.72M | -37.4M | 36.58M | 11.63M | -11.18M | 65.51M | -82.61M | 7.51M | 32.39M |
| Change in Receivables | -40.39M | 22.21M | -6.47M | 21.9M | -47.79M | 40.76M | -7.72M | 8.19M | -39.5M | 8.35M | 8.13M | 25.4M |
| Change in Inventory | 2.64M | -26.78M | -18.53M | -10.78M | 2.19M | 11.09M | -3.11M | -1.94M | 120K | 5.94M | -4.33M | -5.18M |
| Change in Payables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Investing | -93.74M | 34.01M | -289.62M | -422.01M | -184.36M | 267.71M | -42.67M | -65.92M | -114.93M | -94.42M | -29.6M | -23.75M |
| Capital Expenditures | -1.35M | -37.29M | -3.44M | -1.32M | -1.72M | -3.77M | -522K | 7.38M | -9.59M | -5.57M | -6.36M | -6.25M |
| CapEx % of Revenue | 0.5% | 22.64% | 1.63% | 0.74% | 0.15% | 1.77% | 0.27% | 3.95% | 4.56% | 1.81% | 3.23% | 2.92% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | -252.75M | -2.68M | -738K | 147.27M | -10.24M | 28.04M | -54.76M | -22.9M | -22.85M | -13.04M |
| Cash from Financing | 6.4M | 302.5M | 15.22M | 3.96M | 9.41M | 26.47M | -17.63M | 246.48M | 540K | 620.49M | 3.36M | 18.46M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 1.49M | 0 | 0 | -1.49M | -300M | 0 | 0 |
| Equity Issued (Net) | 6.4M | 62.5M | 0 | 0 | 15.75M | 26.47M | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 240M | 15.22M | 3.96M | -6.34M | -1.49M | -17.63M | 246.48M | 2.03M | 920.49M | 3.36M | 18.46M |
| Net Change in Cash | -150.66M | 312.03M | -344.77M | -462.79M | 700.55M | 255.53M | -128.75M | 103.92M | -45.66M | 428.87M | -43.09M | -9.1M |
| Free Cash Flow | -60.24M | -36.65M | -69.75M | -62.33M | 867.57M | -36.5M | -87.77M | -64.08M | 6.41M | -128.75M | -43.73M | -33.4M |
| FCF Margin % | -22.1% | -22.25% | -33.05% | -34.84% | 73.77% | -17.12% | -44.6% | -34.32% | 3.05% | -41.93% | -22.24% | -15.62% |
| FCF Growth % | -106.94% | -0.4% | 20.53% | 2.73% | 13434.65% | 71.65% | -100.73% | -91.83% | 108.76% | 33.28% | 31.75% | 54.39% |
| FCF per Share | -0.73 | -0.45 | -0.80 | -0.80 | 10.04 | -0.47 | -1.14 | -0.84 | 0.08 | -1.71 | -0.58 | -0.45 |
| FCF Conversion (FCF/Net Income) | 21.02x | 0.25x | -4.17x | 0.90x | 1.00x | 0.46x | 0.72x | 0.72x | -0.77x | 0.64x | 0.11x | 0.07x |
| Interest Paid | 0 | 0 | 0 | 0 | 2.16M | -3.67M | 2.16M | 0 | 3.67M | 2.11M | 11.71M | 9.35M |
| Taxes Paid | 0 | 0 | 0 | 36.15M | 3.04M | -12.78M | 6.66M | 4.08M | 2.04M | 524K | 4.43M | 6.98M |